Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Arthrosis
Interventions
DRUG

Tranexamic Acid - topical

Tranexamic acid is an antifibrinolytic agent that decreases perioperative blood loss, because it inhibits fibrinolysis by competing with lysine molecule in coupling sites in fibrinogen. In this study arm, the drug is administered topically on the wound.

DRUG

Placebo

100 ml of saline solution administered with anesthesia during 10 minutes

DRUG

Tranexamic Acid - intravenous

Tranexamic acid is an antifibrinolytic agent that decreases perioperative blood loss, because it inhibits fibrinolysis by competing with lysine molecule in coupling sites in fibrinogen. In this arm, the drug is administered intravenously.

All Listed Sponsors
lead

Irmandade da Santa Casa de Misericordia de Sao Paulo

OTHER

NCT02323373 - Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter